Pulmonary carcinoids share a lower rate of mutations compared to their adenocarcinoma counterparts (including very low rates of TP53 and RB1 gene mutations), but have frequent mutations in chromatin-remodeling genes [37, 38]. This evidence concerns the gene TP53 and adenocarcinoma.